BrainChip (BRN) Q3 2026 earnings summary

Executive summary

• Sequora’s commercial release expanded the portfolio into edge generative AI and on-device LLM inference, complementing Akida’s streaming sensor workloads.

• Receipt of ~20,000 AKD1500 chips enabled fulfillment of outstanding orders and increased M.2 and PCIe board production; two IP licensees targeted Q4 2026 tape-outs.

• Quarter-end cash was US$16.366M, representing 3.95 quarters of estimated funding.

Financial highlights

• Customer receipts were US$273K, up from US$150K in the prior quarter; net operating cash outflow was US$4.313M, down 9% from US$4.7M.

• Supplier and employee payments totaled US$5.0M versus US$5.1M in the prior quarter; R&D was the largest outflow at US$2.122M.

• 9M customer receipts were US$1.086M and net operating cash outflow was US$15.567M.

Outlook and guidance

• Near-term priorities include supporting EdgeAI and Frontgrade Gaisler tape-outs, converting advanced pipeline opportunities, completing AKD2500 tape-out, expanding board sales and progressing Sequora engagements.

• EdgeAI targets an MPW tape-out in December 2026, with engineering samples expected in Q1 2027; Frontgrade Gaisler expects GR801 tape-out in the coming months and silicon production in 2027.

• AKD2500 tape-out remains on track for December 2026; first engineering samples are expected in early Q3 2027, subject to foundry capacity.

• First royalty-producing programs could generate revenue from late 2027; timing and amount depend on customer production schedules and sales.